Immunotherapy News and Research

Latest Immunotherapy News and Research

PCRF awards £1.2M grants for new research projects tackling pancreatic cancer

Seven innovative research projects tackling pancreatic cancer have been awarded grants totalling £1.2M by the UK medical research charity, Pancreatic Cancer Research Fund.

28 May 2019

Scientists use gold nanoparticles to edit genes tied to HIV, inherited blood disorders

Scientists at Fred Hutchinson Cancer Research Center took a step toward making gene therapy more practical by simplifying the way gene-editing instructions are delivered to cells.

28 May 2019

Genetically eliminating TOX factors improves eradication of solid tumors in CAR T model

A decade ago researchers announced development of a cancer immunotherapy called CAR (for chimeric antigen receptor)-T, in which a patient is re-infused with their own genetically modified T cells equipped to mount a potent anti-tumor attack.

28 May 2019

Skin patch may be useful in treating children with milk-induced EoE

A new study from Children's Hospital of Philadelphia finds that a skin patch may be useful in treating children with a painful, chronic condition called eosinophilic esophagitis triggered by milk.

23 May 2019

Scientists identify target to ‘tone down’ hyper-active immunity to influenza infection

For most people, the influenza A virus, commonly known as the flu, is cleared from the body by our own immune system.

23 May 2019

Immunotherapy is the most prominent topic in skin cancer research, report reveals

A new report published today highlights the different research areas in the field of skin cancer, showing that immunotherapy is the most prominent topic and reveals the countries that are driving this research.

21 May 2019

Neurological Side Effects of CAR T-Cell Therapy Revealed

Researchers at Brigham and Women’s Hospital quantified the neurological symptoms associated with CAR T-cell therapy and found that 77 percent of patients receiving the treatment experienced at least one neurological side effect.

16 May 2019

Probiotic-derived molecule optimizes the immune system to combat viral inflammatory diseases

The existence of certain microorganisms in your gut may bolster the immune system's ability to fend off a herpes viral attack that can cause fatal brain inflammation, reports a new City of Hope-led study.

14 May 2019

Quanterix corporation releases operating results for first quarter 2019

Quanterix announced financial results for the three months ended March 31, 2019.

From Quanterix 10 May 2019

Computational tool uses patient's genomic data to find best treatment for bladder cancer

When it comes to cancer, one-size-does-not-fit-all.One of the challenges that we have when taking care of patients with bladder cancer is that from one patient to the next, the prognosis, the stage and the response to different kinds of treatment differ.

10 May 2019

Genomics study reveals five genes linked to treatment resistance in prostate cancer

A new genomics study has found that men are three times more likely to die from prostate cancer if they possess mutations the retinoblastoma 1 (RB1) gene.

8 May 2019

Unexpected role of junk RNA in cancer opens new way for treatment of the disease

In an article just published by Trends in Cancer online, Dr. Alan Herbert, founder at InsideOutBio, highlights how the way cancer cells solve the problem of junk RNA makes them vulnerable to a new type of cancer therapy.

7 May 2019

Biomarker may help predict first treatment option for metastatic colorectal cancer patients

Foundational research by a City of Hope physician-scientist and his colleagues could one day help metastatic colorectal cancer patients decide whether to choose immunotherapy or chemotherapy as their first treatment option.

2 May 2019

Researchers win $6.2 million grant to study HIV/TB co-infection in children

About a third of us are walking around with the bacteria that causes tuberculosis in our bodies, but most don't actually end up with TB. For children living with HIV - about 2 million at last estimate - it's a different story.

1 May 2019

Angiotensin receptor blockers could improve response to cancer immunotherapy

A research team led by investigators at Massachusetts General Hospital and the Massachusetts Institute of Technology has found that combining a specialized version of an antihypertension drug with immune checkpoint blockers could increase the effectiveness of cancer immunotherapies.

30 Apr 2019

Immunotherapy News and Research

Latest Immunotherapy News and Research

PCRF awards £1.2M grants for new research projects tackling pancreatic cancer

Scientists use gold nanoparticles to edit genes tied to HIV, inherited blood disorders

Genetically eliminating TOX factors improves eradication of solid tumors in CAR T model

Skin patch may be useful in treating children with milk-induced EoE

Scientists identify target to ‘tone down’ hyper-active immunity to influenza infection

Immunotherapy is the most prominent topic in skin cancer research, report reveals

Neurological Side Effects of CAR T-Cell Therapy Revealed

Probiotic-derived molecule optimizes the immune system to combat viral inflammatory diseases

Quanterix corporation releases operating results for first quarter 2019

Computational tool uses patient's genomic data to find best treatment for bladder cancer

Genomics study reveals five genes linked to treatment resistance in prostate cancer

Unexpected role of junk RNA in cancer opens new way for treatment of the disease

Biomarker may help predict first treatment option for metastatic colorectal cancer patients

Researchers win $6.2 million grant to study HIV/TB co-infection in children

Angiotensin receptor blockers could improve response to cancer immunotherapy

Mesothelioma patients twice as likely to survive when treated with high dose of radiation

Peanut allergy tolerance treatment may increase the risk of anaphylaxis

Three studies show how tumors hijack the immune system to develop radiotherapy resistance

Researchers complete large analysis of new gene fusion responsible for development of cancers

Cancer cells use tactics to avoid being recognised by immunotherapy agents

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Immunotherapy News and Research

Latest Immunotherapy News and Research

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in